Obesity is the most prevalent chronic condition, although it was not officially recognized as a disease until 2013. Obesity is complex and directly contributes to many other chronic conditions. Recently, new medications have become available, which are valuable tools for the treatment of obesity. With or without medication, lifestyle interventions remain fundamental in the treatment of obesity. As demonstrated by the case presented, even patients with severe obesity (BMI 45.8) can achieve remarkable improvement (BMI 31.7) through intensive lifestyle interventions without medication. Achieving weight loss significantly improves clinical outcomes and helps curb the rise of obesity and its complications. Providers are well positioned to provide intensive lifestyle therapeutic interventions for patients with obesity.
EnginA. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1-17. doi:10.1007/978-3-319-48382-5_1
2.
MarraMSammarcoRDe LorenzoA, et al.Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X-Ray absorptiometry (DXA): a critical overview. Contrast Media Mol Imaging. 2019;2019:3548284. doi:10.1155/2019/3548284. Published 2019 May 29.
3.
RossRNeelandIJYamashitaS, et al.Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177-189. doi:10.1038/s41574-019-0310-7
4.
ChandonPWansinkB. Does food marketing need to make us fat? A review and solutions. Nutr Rev. 2012;70(10):571-593. doi:10.1111/j.1753-4887.2012.00518.x
5.
McAllisterEJDhurandharNVKeithSW, et al.Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49(10):868-913. doi:10.1080/10408390903372599
6.
Elmaleh-SachsASchwartzJLBramanteCTNicklasJMGudzuneKAJayM. Obesity management in adults: a review. JAMA. 2023;330(20):2000-2015. doi:10.1001/jama.2023.19897
7.
LeeDCSuiXChurchTSLavieCJJacksonASBlairSN. Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol. 2012;59(7):665-672. doi:10.1016/j.jacc.2011.11.013
8.
FlegalKMKitBKOrpanaHGraubardBI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71-82. doi:10.1001/jama.2012.113905
9.
AtlasSJKimKNhanE, et al.Medications for obesity management: effectiveness and value. J Manag Care Spec Pharm. 2023;29(5):569-575. doi:10.18553/jmcp.2023.29.5.569. Correction in: J Manag Care Spec Pharm. 2023;29(6):712. doi:10.18553/jmcp.2023.29.6.712.
10.
BergSStickleHRoseSJNemecEC. Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis. Obes Rev. 2025;26:e13929. doi:10.1111/obr.13929. Published online April 4.
11.
GleasonPPUrickBYMarshallLZFriedlanderNQiuYLeslieRS. Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. J Manag Care Spec Pharm. 2024;30(8):860-867. doi:10.18553/jmcp.2024.23332
12.
HsuREiseltAKKompalaT. Expanding lifestyle intervention beyond “diet and exercise” in the GLP-1RA era. Int J Obes. 2025;49:1419-1420. doi:10.1038/s41366-025-01767-9. Published online April 10, 2025.
13.
ClaytonTLFitchABaysHE. Obesity and hypertension: obesity medicine association (OMA) clinical practice statement (CPS) 2023. Obes Pillars. 2023;8:100083. doi:10.1016/j.obpill.2023.100083. Published 2023 Aug 7.
14.
US Preventive Services Task ForceCurrySJKristAH, et al.Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement. JAMA. 2018;320(11):1163-1171. doi:10.1001/jama.2018.13022
15.
RippeJM. The academic basis of lifestyle medicine. Am J Lifestyle Med. 2023;18(4):497-511. doi:10.1177/15598276231212825
16.
WrightNWilsonLSmithMDuncanBMcHughP. The BROAD study: a randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes. Nutr Diabetes. 2017;7(3):e256. doi:10.1038/nutd.2017.3
17.
BassinSRFerreira De CarvalhoJGulatiM. A review of plant-based diets for obesity management. Endocr Pract. 2024;30(8):779-789. doi:10.1016/j.eprac.2024.04.020
18.
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. 2nd ed.Washington, DC: U.S. Department of Health and Human Services; 2018.
19.
JayediASoltaniSEmadiAZargarMSNajafiA. Aerobic exercise and weight loss in adults: a systematic review and dose-response meta-analysis. JAMA Netw Open. 2024;7(12):e2452185. doi:10.1001/jamanetworkopen.2024.52185
20.
OrtegaFBLavieCJBlairSN. Obesity and cardiovascular disease. Circ Res. 2016;118(11):1752-1770. doi:10.1161/CIRCRESAHA.115.306883
21.
SwiftDLJohannsenNMLavieCJEarnestCPChurchTS. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis. 2014;56(4):441-447. doi:10.1016/j.pcad.2013.09.012
22.
SchwartzMWSeeleyRJZeltserLM, et al.Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev. 2017;38(4):267-296. doi:10.1210/er.2017-00111
23.
WaddenTATronieriJSButrynML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol. 2020;75(2):235-251. doi:10.1037/amp0000517
24.
FrostHCampbellPMaxwellM, et al.Effectiveness of motivational interviewing on adult behaviour change in health and social care settings: a systematic review of reviews. PLoS One. 2018;13(10):e0204890. doi:10.1371/journal.pone.0204890. Published 2018 Oct 18.
25.
ChenJKaurHJaquesJ, et al.Association of clinically significant weight loss with number of patient visits and months of attendance at an Australian multidisciplinary weight management clinic. Clin Obes. 2022;12(3):e12520. doi:10.1111/cob.12520
26.
SaranapalaDMMKBaranoffJRushworthRL, et al.The effect of cognitive behavioral stress management on perceived stress, biological stress markers and weight loss/regain, from a diet-induced weight loss program: a randomized controlled trial. Compr Psychoneuroendocrinol. 2022;10:100124. doi:10.1016/j.cpnec.2022.100124
27.
BublitzMAdraNHijaziLShaibFAttarianHBourjeilyG. A narrative review of sex and gender differences in sleep disordered breathing: gaps and opportunities. Life. 2022;12(12):2003. doi:10.3390/life12122003. Published 2022 Dec 1.
28.
WestreichRGozlan-TalmorAGeva-RobinsonS, et al.The presence of snoring as well as its intensity is underreported by women. J Clin Sleep Med. 2019;15(3):471-476. doi:10.5664/jcsm.7678. Published 2019 Mar 15.
